Jones S and Howl J |
Cannabinoid receptor systems: therapeutic targets for tumour intervention. |
2003 |
Expert Opin. Ther. Targets |
pmid:14640910
|
Shiraishi T et al. |
The presence of ceramidase activity in liver nuclear membrane. |
2003 |
Biol. Pharm. Bull. |
pmid:12808285
|
Klegeris A et al. |
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. |
2003 |
Br. J. Pharmacol. |
pmid:12813001
|
Kasai HF et al. |
Analyses of anandamide and endocannabinoid-like compounds using collision-induced dissociation in fast atom bombardment ionization-mass spectrometry and gas chromatography/chemical ionization-mass spectrometry. |
2003 |
Anal Sci |
pmid:14696920
|
Gaetani S et al. |
Anandamide hydrolysis: a new target for anti-anxiety drugs? |
2003 |
Trends Mol Med |
pmid:14604824
|
Maccarrone M et al. |
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism. |
2003 |
J. Neurochem. |
pmid:12716433
|
Marinelli S et al. |
Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. |
2003 |
J. Neurosci. |
pmid:12716921
|
Fasia L et al. |
Uptake and metabolism of [3H]anandamide by rabbit platelets. Lack of transporter? |
2003 |
Eur. J. Biochem. |
pmid:12919314
|
Marsicano G et al. |
CB1 cannabinoid receptors and on-demand defense against excitotoxicity. |
2003 |
Science |
pmid:14526074
|
Chu CJ et al. |
N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. |
2003 |
J. Biol. Chem. |
pmid:12569099
|
Chen P et al. |
Metabolism of anandamide in cerebral microvascular endothelial cells. |
2004 |
Prostaglandins Other Lipid Mediat. |
pmid:15165032
|
Breivogel CS et al. |
Cannabinoid signaling in rat cerebellar granule cells: G-protein activation, inhibition of glutamate release and endogenous cannabinoids. |
2004 |
Neuropharmacology |
pmid:15165836
|
Kim J and Alger BE |
Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. |
2004 |
Nat. Neurosci. |
pmid:15184902
|
Kohro S et al. |
Reductions in levels of bacterial superantigens/cannabinoids by plasma exchange in a patient with severe toxic shock syndrome. |
2004 |
Anaesth Intensive Care |
pmid:15675223
|
Witting A et al. |
Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice. |
2004 |
J. Neurochem. |
pmid:15189359
|
Peroni RN et al. |
Sex-linked differences in the vasorelaxant effects of anandamide in vascular mesenteric beds: role of oestrogens. |
2004 |
Eur. J. Pharmacol. |
pmid:15189776
|
Seagard JL et al. |
Anandamide content and interaction of endocannabinoid/GABA modulatory effects in the NTS on baroreflex-evoked sympathoinhibition. |
2004 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:14615281
|
Johnson RP et al. |
System-specific O2 sensitivity of the tandem pore domain K+ channel TASK-1. |
2004 |
Am. J. Physiol., Cell Physiol. |
pmid:14576090
|
Price TJ et al. |
Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. |
2004 |
Br. J. Pharmacol. |
pmid:15006899
|
Egashira N et al. |
Anandamide inhibits the DOI-induced head-twitch response in mice. |
2004 |
Psychopharmacology (Berl.) |
pmid:14586538
|
Movsesyan VA et al. |
Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways. |
2004 |
Cell Death Differ. |
pmid:15375383
|
Giuffrida A et al. |
Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. |
2004 |
Neuropsychopharmacology |
pmid:15354183
|
Kelley BG and Thayer SA |
Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors. |
2004 |
Eur. J. Pharmacol. |
pmid:15288572
|
McFarland MJ et al. |
A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide. |
2004 |
J. Biol. Chem. |
pmid:15292270
|
Lazzarin N et al. |
Fluctuations of fatty acid amide hydrolase and anandamide levels during the human ovulatory cycle. |
2004 |
Gynecol. Endocrinol. |
pmid:15293893
|
Do Y et al. |
Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation. |
2004 |
J. Immunol. |
pmid:15294950
|
Blázquez C et al. |
Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. |
2004 |
Cancer Res. |
pmid:15313899
|
Oka S et al. |
2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils. |
2004 |
J. Leukoc. Biol. |
pmid:15316028
|
Wiley JL et al. |
A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats. |
2004 |
Exp Clin Psychopharmacol |
pmid:15301634
|
McAllister SD et al. |
Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation. |
2004 |
J. Biol. Chem. |
pmid:15326174
|
Di Marzo V et al. |
The anandamide membrane transporter. Structure-activity relationships of anandamide and oleoylethanolamine analogs with phenyl rings in the polar head group region. |
2004 |
Bioorg. Med. Chem. |
pmid:15351399
|
Scorticati C et al. |
The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen. |
2004 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:15280536
|
Rockwell CE and Kaminski NE |
A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:15284281
|
Yue HY et al. |
AM404 enhances the spontaneous release of L-glutamate in a manner sensitive to capsazepine in adult rat substantia gelatinosa neurones. |
2004 |
Brain Res. |
pmid:15276889
|
Akerman S et al. |
Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors. |
2004 |
Br. J. Pharmacol. |
pmid:15277315
|
Ortega-Gutiérrez S et al. |
Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake. |
2004 |
Biochemistry |
pmid:15209515
|
D'Amico M et al. |
Inhibition by anandamide and synthetic cannabimimetics of the release of [3H]D-aspartate and [3H]GABA from synaptosomes isolated from the rat hippocampus. |
2004 |
Neurochem. Res. |
pmid:15260134
|
Boldrup L et al. |
A simple stopped assay for fatty acid amide hydrolase avoiding the use of a chloroform extraction phase. |
2004 |
J. Biochem. Biophys. Methods |
pmid:15262451
|
Lichtman AH et al. |
Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:15229230
|
Barros DM et al. |
Interactions between anandamide-induced anterograde amnesia and post-training memory modulatory systems. |
2004 |
Brain Res. |
pmid:15234253
|
Karlsson M et al. |
Reversible, temperature-dependent, and AM404-inhibitable adsorption of anandamide to cell culture wells as a confounding factor in release experiments. |
2004 |
Eur J Pharm Sci |
pmid:15158903
|
González S et al. |
Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence. |
2004 |
Drug Alcohol Depend |
pmid:15099659
|
Centonze D et al. |
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission. |
2004 |
Neuropsychopharmacology |
pmid:15100701
|
McQueen DS et al. |
Cannabidiol lacks the vanilloid VR1-mediated vasorespiratory effects of capsaicin and anandamide in anaesthetised rats. |
2004 |
Eur. J. Pharmacol. |
pmid:15140635
|
Fowler CJ et al. |
Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle. |
2004 |
Eur. J. Pharmacol. |
pmid:15145699
|
Maccarrone M et al. |
Enhanced anandamide degradation is associated with neuronal apoptosis induced by the HIV-1 coat glycoprotein gp120 in the rat neocortex. |
2004 |
J. Neurochem. |
pmid:15147522
|
O'Sullivan SE et al. |
Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries. |
2004 |
Br. J. Pharmacol. |
pmid:15148250
|
Parkkari T et al. |
Synthesis and CB1 receptor activities of novel arachidonyl alcohol derivatives. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:15149681
|
Pacher P et al. |
Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice. |
2004 |
J. Physiol. (Lond.) |
pmid:15121805
|
Van Der Stelt M and Di Marzo V |
Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels. |
2004 |
Eur. J. Biochem. |
pmid:15128293
|
Randall MD et al. |
The complexities of the cardiovascular actions of cannabinoids. |
2004 |
Br. J. Pharmacol. |
pmid:15131000
|
Fegley D et al. |
Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. |
2004 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:15138300
|
Fernandez-Espejo E and Galan-Rodriguez B |
Sensorimotor gating in mice is disrupted after AM404, an anandamide reuptake and degradation inhibitor. |
2004 |
Psychopharmacology (Berl.) |
pmid:15088080
|
Valenti M et al. |
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain. |
2004 |
Cell. Mol. Life Sci. |
pmid:15095014
|
Kishimoto S et al. |
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells. |
2004 |
J. Biochem. |
pmid:15115777
|
Gardener MJ et al. |
Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries. |
2004 |
Br. J. Pharmacol. |
pmid:15066906
|
Weber A et al. |
Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry. |
2004 |
J. Lipid Res. |
pmid:14729864
|
Kraft B et al. |
Cannabinoid receptor-independent suppression of the superoxide generation of human neutrophils (PMN) by CP55 940, but not by anandamide. |
2004 |
Life Sci. |
pmid:15193957
|
de Lago E et al. |
In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake. |
2004 |
Eur. J. Pharmacol. |
pmid:14744610
|
Dennedy MC et al. |
Cannabinoids and the human uterus during pregnancy. |
2004 |
Am. J. Obstet. Gynecol. |
pmid:14749627
|
Moezi L et al. |
Potentiation of anandamide effects in mesenteric beds isolated from bile duct-ligated rats: role of nitric oxide. |
2004 |
Eur. J. Pharmacol. |
pmid:14751408
|
Piomelli D |
THC: moderation during implantation. |
2004 |
Nat. Med. |
pmid:14702623
|
Arizzi MN et al. |
Behavioral effects of inhibition of cannabinoid metabolism: The amidase inhibitor AM374 enhances the suppression of lever pressing produced by exogenously administered anandamide. |
2004 |
Life Sci. |
pmid:14672756
|
MartÃnez-González D et al. |
Oleamide and anandamide effects on food intake and sexual behavior of rats. |
2004 |
Neurosci. Lett. |
pmid:15193744
|
Lees G and Dougalis A |
Differential effects of the sleep-inducing lipid oleamide and cannabinoids on the induction of long-term potentiation in the CA1 neurons of the rat hippocampus in vitro. |
2004 |
Brain Res. |
pmid:14715144
|
Ruiz-Llorente L et al. |
Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study. |
2004 |
Br. J. Pharmacol. |
pmid:14718261
|
Huitron-Resendiz S et al. |
Characterization of the sleep-wake patterns in mice lacking fatty acid amide hydrolase. |
2004 |
Sleep |
pmid:15453543
|
Akerman S et al. |
Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:14718591
|
Maccarrone M |
Inhibition of anandamide hydrolysis: cells also know how to do it. |
2004 |
Trends Mol Med |
pmid:14720580
|
Bátkai S et al. |
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. |
2004 |
Circulation |
pmid:15451779
|
Contassot E et al. |
Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1. |
2004 |
J. Neuropathol. Exp. Neurol. |
pmid:15453094
|
Golech SA et al. |
Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. |
2004 |
Brain Res. Mol. Brain Res. |
pmid:15548432
|
Battista N et al. |
Endocannabinoids and their involvement in the neurovascular system. |
2004 |
Curr Neurovasc Res |
pmid:16185189
|
Mukherjee S et al. |
Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors. |
2004 |
Eur. J. Pharmacol. |
pmid:15556131
|
Oliver D et al. |
Functional conversion between A-type and delayed rectifier K+ channels by membrane lipids. |
2004 |
Science |
pmid:15031437
|
de Lago E et al. |
Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence. |
2004 |
Brain Res. |
pmid:15064146
|
Cernak I et al. |
The "dark side" of endocannabinoids: a neurotoxic role for anandamide. |
2004 |
J. Cereb. Blood Flow Metab. |
pmid:15129189
|
Costanzi M et al. |
Effects of anandamide and morphine combinations on memory consolidation in cd1 mice: involvement of dopaminergic mechanisms. |
2004 |
Neurobiol Learn Mem |
pmid:14990234
|
Steffens M et al. |
Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex. |
2004 |
Br. J. Pharmacol. |
pmid:14993102
|
Sun YX et al. |
Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D. |
2004 |
Biochem. J. |
pmid:14998370
|
Berger C et al. |
Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia? |
2004 |
J. Neurochem. |
pmid:15009671
|
Fernandez-Espejo E et al. |
Experimental parkinsonism alters anandamide precursor synthesis, and functional deficits are improved by AM404: a modulator of endocannabinoid function. |
2004 |
Neuropsychopharmacology |
pmid:15010694
|
Cruz F |
Mechanisms involved in new therapies for overactive bladder. |
2004 |
Urology |
pmid:15013655
|
Joseph J et al. |
Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes. |
2004 |
Cancer Immunol. Immunother. |
pmid:15034673
|
Ligresti A et al. |
Further evidence for the existence of a specific process for the membrane transport of anandamide. |
2004 |
Biochem. J. |
pmid:14969584
|
Guo J and Ikeda SR |
Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. |
2004 |
Mol. Pharmacol. |
pmid:14978245
|
Basta PV et al. |
Preparation of monoclonal antibodies reactive to the endogenous small molecule, anandamide. |
2004 |
J. Immunol. Methods |
pmid:14980433
|
Fernández-Solari J et al. |
Alcohol inhibits luteinizing hormone-releasing hormone release by activating the endocannabinoid system. |
2004 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:14981261
|
Evans RM et al. |
Multiple actions of anandamide on neonatal rat cultured sensory neurones. |
2004 |
Br. J. Pharmacol. |
pmid:15023857
|
Piomelli D |
The endogenous cannabinoid system and the treatment of marijuana dependence. |
2004 |
Neuropharmacology |
pmid:15464150
|
Fernández-Rodriguez CM et al. |
Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis. |
2004 |
Liver Int. |
pmid:15482346
|
Triggle CR et al. |
The endothelium in health and disease: a discussion of the contribution of non-nitric oxide endothelium-derived vasoactive mediators to vascular homeostasis in normal vessels and in type II diabetes. |
2004 |
Mol. Cell. Biochem. |
pmid:15524164
|
Holt S et al. |
Lipopolysaccharide-induced pulmonary inflammation is not accompanied by a release of anandamide into the lavage fluid or a down-regulation of the activity of fatty acid amide hydrolase. |
2004 |
Life Sci. |
pmid:15530507
|
Habayeb OM et al. |
Plasma levels of the endocannabinoid anandamide in women--a potential role in pregnancy maintenance and labor? |
2004 |
J. Clin. Endocrinol. Metab. |
pmid:15531501
|
Muthian S et al. |
Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia. |
2004 |
Neuroscience |
pmid:15541895
|
McFarland MJ and Barker EL |
Anandamide transport. |
2004 |
Pharmacol. Ther. |
pmid:15518883
|
Ghafouri N et al. |
Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. |
2004 |
Br. J. Pharmacol. |
pmid:15492019
|
Lanzafame AA et al. |
Effects of anandamide on the binding and signaling properties of M1 muscarinic acetylcholine receptors. |
2004 |
Biochem. Pharmacol. |
pmid:15498511
|
Motobe T et al. |
Endogenous cannabinoids are candidates for lipid mediators of bone cement implantation syndrome. |
2004 |
Shock |
pmid:14676677
|
De Petrocellis L et al. |
Actions of two naturally occurring saturated N-acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels. |
2004 |
Br. J. Pharmacol. |
pmid:15289293
|